Glucagon like Peptide 1 News and Research

RSS

FDA approves first non-insulin drug for treatment of pediatric patients with type 2 diabetes

The U.S. Food and Drug Administration today approved Victoza (liraglutide) injection for treatment of pediatric patients 10 years or older with type 2 diabetes.

18 Jun 2019

Diabetes drug reduces cardiovascular events and kidney problems, study finds

A clinical trial that followed more than 9,900 people in 24 countries has found that the drug dulaglutide reduced cardiovascular events and kidney problems in middle-aged and older people with Type 2 diabetes.

10 Jun 2019

Diabetes drug could help with smoking cessation

Phillip Robinson has gone from 10 cigarettes a day to one or two every other day after enrolling in a smoking cessation clinical trial launched by researchers at The University of Texas Health Science Center at Houston

30 Apr 2019

New review on relationship between COPD and Type 2 diabetes

Chronic obstructive pulmonary disease is characterized by a chronic airflow obstruction that is associated with severe global mortality and morbidity.

23 Apr 2019

Bariatric surgery changes the way our body senses food

How bariatric surgery helps people with obesity and diabetes is related to changes in the way the gut senses food and nutrients after the operation, researchers report February 5 in the journal Cell Reports.

8 Feb 2019

GW researchers receive NIH funding to study causes of high risk of heart disease in HIV patients

Atherosclerosis and cardiovascular disease are major complications of HIV infection and cannot currently be treated by antiretroviral treatments.

21 Dec 2018

New bacterial species may help fight obesity and metabolic disorders

The MyNewGut project has discovered new bacterial species and strains in healthy people that seem to be effective against obesity, metabolic and mental disorders related to stress and obesity (e.g. depression).

17 Dec 2018

Liraglutide drug associated with lower risk of cardiovascular events

Real world data from a large Nordic study shows that use of liraglutide, a drug for type 2 diabetes, is associated with a lower risk of myocardial infarction, stroke or cardiovascular death.

6 Dec 2018

Study investigates effects of glucose-lowering drug in preventing damage to the kidneys

New research presented at the annual meeting of the European Association for the Study of Diabetes and published simultaneously in The Lancet Diabetes & Endocrinology shows how the glucose-lowering drug lixisenatide can slow or prevent damage to the kidneys in macro-albuminuric patients with type 2 diabetes mellitus and cardiovascular disease.

3 Oct 2018

University of Pennsylvania expert investigates novel treatment for cocaine addiction

Cocaine and other drugs of abuse hijack the natural reward circuits in the brain. In part, that's why it's so hard to quit using these substances.

28 Apr 2018

Bariatric surgery successes pave way for new type 2 diabetes treatment

Bariatric surgery has long yielded almost immediate health benefits for patients with type 2 diabetes, and new findings on the reasons for remission may be the key to developing drug alternatives to surgery.

25 Apr 2018

Study compares survival outcomes of different drugs for type 2 diabetes

In a comparison of different classes of drugs used to lower blood sugar levels for patients with type 2 diabetes, sodium-glucose cotransporter 2 (SGLT-2) inhibitors or glucagon-like peptide 1(GLP-1) agonists were associated with a lower risk of death than dipeptidyl peptidase 4 (DPP-4) inhibitors or control (placebo or no treatment).

17 Apr 2018

Glucagon like Peptide 1 News and Research

FDA approves first non-insulin drug for treatment of pediatric patients with type 2 diabetes

Diabetes drug reduces cardiovascular events and kidney problems, study finds

Diabetes drug could help with smoking cessation

New review on relationship between COPD and Type 2 diabetes

Bariatric surgery changes the way our body senses food

GW researchers receive NIH funding to study causes of high risk of heart disease in HIV patients

New bacterial species may help fight obesity and metabolic disorders

Liraglutide drug associated with lower risk of cardiovascular events

Study investigates effects of glucose-lowering drug in preventing damage to the kidneys

University of Pennsylvania expert investigates novel treatment for cocaine addiction

Bariatric surgery successes pave way for new type 2 diabetes treatment

Study compares survival outcomes of different drugs for type 2 diabetes

One class of diabetes drug not associated with reduced risk of death

New diabetes drug may help obese people shed body weight

Scientists uncover detailed map of the brain circuits behind thirst and satiety

Gastric bypass can provide better outcomes for patients with obesity and diabetes than lifestyle intervention

Chemist finds how to control blood sugar without usual side effects

Scientists take step toward solving puzzle about heart health in type 2 diabetes

UB researcher explores link between signals in the brain's reward system and overeating, drug addiction

New discovery in beta-cell pathway shows potential to improve effectiveness of diabetes drugs

Speeding Up Sample Preparation to Accelerate Analytical Chemistry

Ask the Expert: 7 Questions about Colorectal Cancer & Non-invasive Fecal DNA Testing

Snapping at new biotech breakthroughs with Gator Pro

Latest News

Neuroscience eBook